Indiana Haemophilia Project's New Study Published

04/01/2019

Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources

Read the Complete Paper

The proof is in the research: Less visits to the ER, better compliance with prophylaxis and ability to self-infuse are just some of the benefits experienced more by Indiana residents who seek bleeding disorder treatment at an HTC than those who go elsewhere—this, despite these patients being more likely to have severe illness.

We’re excited to share that the Indiana Haemophilia Surveillance Project—a collaboration between IHTC, the Indiana State Department of Health and the CDC—just published its latest findings after dusting off a 20-year-old study to reaffirm the benefits of HTC care.

These significant findings and more can be found in the complete paper, here.